Escape from IFN-γ-dependent immunosurveillance in tumorigenesis

CF Lin, CM Lin, KY Lee, SY Wu, PH Feng… - Journal of biomedical …, 2017 - Springer
Immune interferon (IFN), also known as IFN-γ, promotes not only immunomodulation but
also antimicrobial and anticancer activity. After IFN-γ binds to the complex of IFN-γ receptor …

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing

I Dasgupta, TR Flotte, AM Keeler - Human gene therapy, 2021 - liebertpub.com
Precise gene manipulation by gene editing approaches facilitates the potential to cure
several debilitating genetic disorders. Gene modification stimulated by engineered …

HLA class I antigens in human tumors

F Garrido, T Cabrera, MA Lopez-Nevot… - Advances in cancer …, 1995 - Elsevier
Publisher Summary This chapter focuses on the abnormal major histocompatibility complex
(MHC) expression detected in human tumors as well as on the biological role that these …

Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors

GJ Nabel, A Chang, EG Nabel, G Plautz… - Human gene …, 1992 - liebertpub.com
Scientific Abstract The goal of immunotherapy is to stimulate the immune system by
modification of tumor cells or expansion of lymphocytes which respond specifically to tumor …

Methylcholanthrene‐induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression

AM Engel, IM Svane, SR Mouritsen, JR Rygaard… - Apmis, 1996 - Wiley Online Library
In order to study the role of the T‐cell‐mediated immune defense in tumor development, a
total of 93 sarcomas were induced using different doses (8 μg (0.1%), 40 μg (0.5%) and 400 …

Plasmids suitable for gene therapy

GJ Nabel, EG Nabel, D Lew, M Marquet - US Patent 5,910,488, 1999 - Google Patents
US5910488A - Plasmids suitable for gene therapy - Google Patents US5910488A - Plasmids
suitable for gene therapy - Google Patents Plasmids suitable for gene therapy Download PDF …

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.

O Blanchet, JF Bourge, H Zinszner, A Israel… - Proceedings of the …, 1992 - pnas.org
Class I antigens encoded in the major histocompatibility complex (MHC)(HLA in man, H-2 in
the mouse) play a key role in the recognition of target cells by cytolytic T lymphocytes. Tumor …

Cancer immunotherapy: are the results discouraging? Can they be improved?

E Kedar, E Klein - Advances in cancer research, 1992 - Elsevier
Publisher Summary Immunization with tumor cells or tumor extracts preventing the growth of
subsequently grafted cells provided the proof for immunogenicity of some animal tumors …

Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro …

PP Doumba, M Nikolopoulou, IP Gomatos… - BMC …, 2013 - Springer
Background Many studies have suggested that the immune response may play a crucial role
in the progression of hepatocellular carcinoma (HCC). Therefore, our aim was to establish a …

DNA binding of regulatory factors interacting with MHC‐class‐I gene enhancer correlates with MHC‐class‐I transcriptional level in class‐I‐defective cell lines

O Blanchet, JF Bourge, H Zinszner… - … journal of cancer, 1991 - Wiley Online Library
Tumor cells frequently show a lack of surface Class‐I major histocompatibility complex
(MHC) antigen expression. These molecules are key recognition structures for immune …